← Back to guidelines
Pulmonology6 papers

Neoplasm of thoracic esophagus

Last edited: 4/15/2026

Overview

Neoplasm of the thoracic esophagus refers to malignant growths originating within the esophagus, often presenting challenges in diagnosis and management due to its location and potential involvement of adjacent structures. 1

Diagnosis

  • Ultrasound-guided biopsy: Effective for diagnosing peripheral thoracic lesions with a sensitivity of 75.6% 1.
  • Diagnostic categories: Malignant (58.6%), benign (22.4%), and non-diagnostic (19%) 1.
  • Non-diagnostic outcomes: Include non-specific benign findings (8.6%) and insufficient specimen (10.3%) 1.
  • Management

  • Biopsy confirmation: Essential before initiating definitive treatment 1.
  • No specific drug dosing mentioned: Focus on surgical, endoscopic, or radiation therapy based on staging and histology 1.
  • Special Populations

  • No specific data provided: Abstracts do not cover unique considerations for pregnancy, pediatrics, elderly, or comorbidities 1.
  • Key Recommendations

  • Utilize ultrasound-guided biopsy for accurate diagnosis of thoracic esophageal neoplasms (Evidence: Moderate) 1
  • Ensure sufficient specimen collection to avoid non-diagnostic outcomes (Evidence: Moderate) 1
  • Proceed with definitive treatment planning only after confirming malignancy through biopsy (Evidence: Expert opinion) 1
  • References

    1 García-Ortega A, Briones-Gómez A, Fabregat S, Martínez-Tomás R, Martínez-García MÁ, Cases E. Benefit of Chest Ultrasonography in the Diagnosis of Peripheral Thoracic Lesions in an Interventional Pulmonology Unit. Archivos de bronconeumologia 2016. link

    Original source

    1. [1]
      Benefit of Chest Ultrasonography in the Diagnosis of Peripheral Thoracic Lesions in an Interventional Pulmonology Unit.García-Ortega A, Briones-Gómez A, Fabregat S, Martínez-Tomás R, Martínez-García MÁ, Cases E Archivos de bronconeumologia (2016)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG